NasdaqGM - Nasdaq Real Time Price USD
Eton Pharmaceuticals, Inc. (ETON)
As of 1:28 PM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 169,570 | 2 |
| Sales | 25,000 | 1 |
| Net Shares Purchased (Sold) | 144,570 | 3 |
| Total Insider Shares Held | 1.39M | -- |
| % Net Shares Purchased (Sold) | 11.60% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| OPALEYE MANAGEMENT, INC. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 6.77 - 7.22 per share. | Indirect | 434,137 | Oct 8, 2024 |
| OPALEYE MANAGEMENT, INC. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 4.65 - 4.75 per share. | Indirect | 504,875 | Sep 11, 2024 |
Related Tickers
HROW Harrow, Inc.
57.66
+2.20%
AQST Aquestive Therapeutics, Inc.
4.9500
0.00%
DERM Journey Medical Corporation
6.07
-4.03%
BFRI Biofrontera Inc.
0.9600
+1.83%
IRWD Ironwood Pharmaceuticals, Inc.
4.1800
-0.24%
SUPN Supernus Pharmaceuticals, Inc.
33.90
+0.68%
ITCI Intra-Cellular Therapies, Inc.
76.87
-0.05%
EGRX Eagle Pharmaceuticals, Inc.
0.7000
-17.65%
ANIP ANI Pharmaceuticals, Inc.
59.78
+0.84%
CYTH Cyclo Therapeutics, Inc.
0.8102
+0.02%